Phase 3 Nintedanib-Chemo Combo Trial Recruits Mesothelioma Patients for Global Study
News
A Phase 3 trial is recruiting 450 participants at clinics worldwide to test whether nintedanib, used in combination with the standard chemotherapy drugs Alimta (pemetrexed) and Platinol (cisplatin) in patients ... Read more